Dandelion extract for metastatic prostate cancer
Part of Cancer, Hormones & metabolism, Kidney & urinary clinical trials.
This trial tests an experimental capsule made from dandelion (called LC-K76) added on top of the usual hormone therapy. The goal is to see if it's safe and effective in men with prostate cancer that has spread beyond the prostate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult male, aged 18 or older.
- You have been newly diagnosed with prostate cancer that has spread to your bones or other organs (like your liver or lungs).
- You have not had any prior treatment for prostate cancer, including surgery, radiation, hormone therapy, or chemotherapy.
- You are not allergic to dandelion or dandelion products.
- You are generally in good health (able to do most daily activities) and are planning to receive standard hormone therapy during this study.
- You do not have poorly controlled diabetes or other serious medical conditions that would interfere with your participation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether giving prostate removal surgery in addition to standard hormone therapy can help men with advanced prostate cancer that has spread to many places. It aims to see if this combination helps them live longer with a better quality of life.
This trial tests a combination of two drugs (darolutamide plus hormone therapy) along with a low dose of chemotherapy (docetaxel) for men whose prostate cancer has spread to other parts of the body. It aims to see if this combined approach is safe and effective.
This trial tests a combination of chemotherapy (docetaxel) and a targeted radiation therapy (lutetium-PSMA) as a first treatment for men whose prostate cancer has spread and no longer responds to hormone therapy. The goal is to see if this combination is safe and effective.
This trial tests a new combination of two drugs for men with advanced prostate cancer that has stopped responding to standard hormone therapy or chemotherapy. The goal is to see if this combination can help shrink tumors or slow the disease.
This Phase 3 study tests HC-1119 soft capsules in men with metastatic castration-resistant prostate cancer—cancer that keeps progressing even when testosterone is blocked. It aims to see whether the drug works better than expected and is safe, especially after prior treatments like abiraterone and/or docetaxel.
This trial tests a new drug called HLD-0915 in men with prostate cancer that has spread. It aims to see how well the drug works and if it's safe.
Hear when a new mHSPC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.